Recognition of Amino Acid Motifs, Rather Than Specific Proteins, by Human Plasma Cell–Derived Monoclonal Antibodies to Posttranslationally Modified Proteins in Rheumatoid Arthritis

Objective Antibodies against posttranslationally modified proteins are a hallmark of rheumatoid arthritis (RA), but the emergence and pathogenicity of these autoantibodies are still incompletely understood. The aim of this study was to analyze the antigen specificities and mutation patterns of monoc...

Full description

Saved in:
Bibliographic Details
Published inArthritis & rheumatology (Hoboken, N.J.) Vol. 71; no. 2; pp. 196 - 209
Main Authors Steen, Johanna, Forsström, Björn, Sahlström, Peter, Odowd, Victoria, Israelsson, Lena, Krishnamurthy, Akilan, Badreh, Sara, Mathsson Alm, Linda, Compson, Joanne, Ramsköld, Daniel, Ndlovu, Welcome, Rapecki, Stephen, Hansson, Monika, Titcombe, Philip J., Bang, Holger, Mueller, Daniel L., Catrina, Anca I., Grönwall, Caroline, Skriner, Karl, Nilsson, Peter, Lightwood, Daniel, Klareskog, Lars, Malmström, Vivianne
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.02.2019
John Wiley and Sons Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective Antibodies against posttranslationally modified proteins are a hallmark of rheumatoid arthritis (RA), but the emergence and pathogenicity of these autoantibodies are still incompletely understood. The aim of this study was to analyze the antigen specificities and mutation patterns of monoclonal antibodies (mAb) derived from RA synovial plasma cells and address the question of antigen cross‐reactivity. Methods IgG‐secreting cells were isolated from RA synovial fluid, and the variable regions of the immunoglobulins were sequenced (n = 182) and expressed in full‐length mAb (n = 93) and also as germline‐reverted versions. The patterns of reactivity with 53,019 citrullinated peptides and 49,211 carbamylated peptides and the potential of the mAb to promote osteoclastogenesis were investigated. Results Four unrelated anti–citrullinated protein autoantibodies (ACPAs), of which one was clonally expanded, were identified and found to be highly somatically mutated in the synovial fluid of a patient with RA. The ACPAs recognized >3,000 unique peptides modified by either citrullination or carbamylation. This highly multireactive autoantibody feature was replicated for Ig sequences derived from B cells from the peripheral blood of other RA patients. The plasma cell–derived mAb were found to target distinct amino acid motifs and partially overlapping protein targets. They also conveyed different effector functions as revealed in an osteoclast activation assay. Conclusion These findings suggest that the high level of cross‐reactivity among RA autoreactive B cells is the result of different antigen encounters, possibly at different sites and at different time points. This is consistent with the notion that RA is initiated in one context, such as in the mucosal organs, and thereafter targets other sites, such as the joints.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Drs. Klareskog and Malmström contributed equally to this work.
Supported by the Knut and Alice Wallenberg Foundation, the European Research Council (grant 250167), the Innovative Medicines Initiative–supported BTCure program (grant 115142‐2), the Swedish Association Against Rheumatism, King Gustaf V's 80‐year Foundation, and the Swedish Medical Research Council.
Drs. Rapecki and Lightwood own stock or stock options in UCB Pharma. Dr. Mathsson Alm owns stock or stock options in Thermo Fischer Scientific.
ISSN:2326-5191
2326-5205
2326-5205
DOI:10.1002/art.40699